Koo PJ - Search Results

1

The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II).

Crawford ED, Petrylak DP, Shore N, Saad F, Slovin SF, Vogelzang NJ, Keane TE, Koo PJ, Gomella LG, O'Sullivan JM, Tombal B, Concepcion RS, Sieber P, Stone NN, Finkelstein SE, Yu EY; Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence (RADAR II) Group. Crawford ED, et al. Among authors: koo pj. Urology. 2017 Jun;104:150-159. doi: 10.1016/j.urology.2016.12.033. Epub 2017 Mar 14. Urology. 2017. PMID: 28302580 Review.

2

A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).

Crawford ED, Koo PJ, Shore N, Slovin SF, Concepcion RS, Freedland SJ, Gomella LG, Karsh L, Keane TE, Maroni P, Penson D, Petrylak DP, Ross A, Mouraviev V, Reiter RE, Divgi C, Yu EY; RADAR III Group. Crawford ED, et al. Among authors: koo pj. J Urol. 2019 Apr;201(4):682-692. doi: 10.1016/j.juro.2018.05.164. J Urol. 2019. PMID: 30077557 Review.

3

Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV.

Crawford ED, Andriole G, Freedland SJ, Garnick M, Gomella LG, Henderson J, Higano CT, Kader AK, Kane C, Keane TE, Koo PJ, Petrylak DP, Reiter RE, Slovin SF, Yu EY. Crawford ED, et al. Among authors: koo pj. Can J Urol. 2020 Oct;27(5):10352-10362. Can J Urol. 2020. PMID: 33049187 Free article. Review.

4

Challenges and recommendations for early identification of metastatic disease in prostate cancer.

Crawford ED, Stone NN, Yu EY, Koo PJ, Freedland SJ, Slovin SF, Gomella LG, Berger ER, Keane TE, Sieber P, Shore ND, Petrylak DP; Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence (RADAR) Group. Crawford ED, et al. Among authors: koo pj. Urology. 2014 Mar;83(3):664-9. doi: 10.1016/j.urology.2013.10.026. Epub 2014 Jan 8. Urology. 2014. PMID: 24411213 Review.

5

Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.

Kim SJ, Koo PJ, Pak K, Kim IJ, Kim K. Kim SJ, et al. Among authors: koo pj. World J Urol. 2018 Mar;36(3):331-340. doi: 10.1007/s00345-017-2168-4. Epub 2018 Jan 2. World J Urol. 2018. PMID: 29294164 Review.

6

The Emerging Role of Next-Generation Imaging in Prostate Cancer.

Murthy V, Aggarwal R, Koo PJ. Murthy V, et al. Among authors: koo pj. Curr Oncol Rep. 2022 Jan;24(1):33-42. doi: 10.1007/s11912-021-01156-1. Epub 2022 Jan 20. Curr Oncol Rep. 2022. PMID: 35059998 Review.

7

Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events.

Kwak JJ, Tirumani SH, Van den Abbeele AD, Koo PJ, Jacene HA. Kwak JJ, et al. Among authors: koo pj. Radiographics. 2015 Mar-Apr;35(2):424-37. doi: 10.1148/rg.352140121. Radiographics. 2015. PMID: 25763727

8

Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET.

Koo PJ, Kwak JJ, Pokharel S, Choyke PL. Koo PJ, et al. Curr Oncol Rep. 2015 Dec;17(12):56. doi: 10.1007/s11912-015-0480-y. Curr Oncol Rep. 2015. PMID: 26462919 Free PMC article. Review.

9

2015 Kocemba-Slosky Fellowship.

Koo P. Koo P. J Nucl Med. 2016 Feb;57(2):10N. J Nucl Med. 2016. PMID: 26833906 Free article. No abstract available.

10

On noting the achievements and future potential of data-driven gating for respiratory motion correction in PET imaging.

Kesner AL, Koo PJ. Kesner AL, et al. Among authors: koo pj. Nucl Med Commun. 2014 Aug;35(8):893. doi: 10.1097/MNM.0000000000000149. Nucl Med Commun. 2014. PMID: 24979590 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page